Counsel
Rebecca Nauta
- Emerging Companies and Venture Capital
REBECCA NAUTA represents emerging and growth stage private companies, venture and growth equity investors, and public companies, on a variety of ongoing and transactional law matters. Rebecca’s practice is focused on the life sciences, biotech, medical device, software, and e-commerce industries, where she advises on a wide range of corporate law matters, including formation, governance, equity and debt financings, securities law, and M&A transactions across all stages of a company’s life cycle.
Experience
- Representative Matters
- Pro Bono
- Astria Therapeutics, Inc. in its acquisition by BioCryst Pharmaceuticals, Inc.
- Respira Therapeutics, Inc. in its option to be acquired by Gossamer Bio, Inc. (Nasdaq: GOSS).
- Orna Therapeutics in its US$80M Series A financing and its US$221 million Series B financing.
Some of the above matters were handled prior to joining Sidley.
Rebecca represented Roxbury Youthworks, a Boston area non-profit organization focused on helping youth caught in cycles of poverty, victimization, and violence successfully transition into adulthood.
Capabilities
SERVICES AND INDUSTRIES
News & Insights
Credentials
Admissions & Certifications
- Massachusetts
Education
- Boston University School of Law, J.D., 2008
- Vassar College, B.A., 2000